BTG (OTCMKTS:BTGGF) Shares Down 0.9%

BTG plc (OTCMKTS:BTGGF) fell 0.9% during mid-day trading on Friday . The stock traded as low as $10.26 and last traded at $10.26, 3,722 shares traded hands during mid-day trading. An increase of 3% from the average session volume of 3,606 shares. The stock had previously closed at $10.35.

The business has a 50-day moving average price of $10.42.

BTG Company Profile (OTCMKTS:BTGGF)

BTG plc acquires, develops, manufactures, and commercializes pharmaceutical products in the United States, Europe, and internationally. It operates through three segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment offers interventional oncology products and systems, such as beads and TheraSphere for treatment of liver cancer; and GALIL medical system, a cryoablation technology for use in kidney cancer and other indications.

Read More: Percentage Gainers

Receive News & Ratings for BTG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG and related companies with MarketBeat.com's FREE daily email newsletter.